Web Stats Provided By Google Analytics

The Raw Stem Cell News Feed

The Stem Cell Research Newswire: Comprehensive Real-Time News Feed for Stem Cell Research

Thursday, April 23, 2015

Tisch MS Research Center Of New York Reports Early Improvement In Stem Cell Trial

Tisch MS Research Center of New York today announced encouraging preliminary results from its FDA-approved Phase I trial using autologous neural stem cells in the treatment of multiple sclerosis . MS is a chronic autoimmune disease of the central nervous system where the myelin sheath is attacked and neurodegeneration may occur.

No comments:

Post a Comment

Popular Stem Cell Roundup Posts